120 related articles for article (PubMed ID: 38306518)
21. Selective treatment of differentiated thyroid carcinoma.
Gemsenjäger E; Heitz PU; Martina B
World J Surg; 1997 Jun; 21(5):546-51; discussion 551-2. PubMed ID: 9204746
[TBL] [Abstract][Full Text] [Related]
22. Predictive value of systemic inflammatory markers for recurrence of papillary thyroid cancer.
Wang G; Ma Y; Liu Y; Fan Y; Miao X; Zhang Y; Zhu H
J Surg Oncol; 2023 Oct; 128(5):743-748. PubMed ID: 37243870
[TBL] [Abstract][Full Text] [Related]
23. Neck recurrence in papillary thyroid carcinoma.
Dedivitis RA; Matos LL; GuimarÃes AV; Castro MAF; Petrarolha SP
Rev Col Bras Cir; 2020; 47():e20202545. PubMed ID: 32844910
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathologic significance of histologic vascular invasion in papillary and follicular thyroid carcinomas.
Furlan JC; Bedard YC; Rosen IB
J Am Coll Surg; 2004 Mar; 198(3):341-8. PubMed ID: 14992733
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of hemithyroidectomy in papillary thyroid carcinoma with minimal extrathyroidal extension.
Ji YB; Song CM; Kim D; Sung ES; Lee DW; Chung MS; Tae K
Eur Arch Otorhinolaryngol; 2019 Dec; 276(12):3435-3442. PubMed ID: 31414221
[TBL] [Abstract][Full Text] [Related]
26. Does the Preoperative Neutrophil-to-lymphocyte Ratio and Platelet-to-lymphocyte Ratio Associate with Clinic-pathological Characteristics in Papillary Carcinoma of Thyroid.
Shrestha BL; Kc AK; Rajbhandari P; Dhakal A; Shrestha KS
Kathmandu Univ Med J (KUMJ); 2021; 19(74):225-229. PubMed ID: 34819441
[TBL] [Abstract][Full Text] [Related]
27. Modified risk stratification based on cervical lymph node metastases following lobectomy for papillary thyroid carcinoma.
Song E; Ahn J; Song DE; Kim WW; Jeon MJ; Sung TY; Kim TY; Chung KW; Kim WB; Shong YK; Hong SJ; Lee YM; Kim WG
Clin Endocrinol (Oxf); 2020 Apr; 92(4):358-365. PubMed ID: 31630423
[TBL] [Abstract][Full Text] [Related]
28. Hemithyroidectomy and ipsilateral central neck dissection for T1 low-risk papillary thyroid cancer: single-institution retrospective observational study.
Giordano D; Botti C; Piana S; Castellucci A; Frasoldati A; Zini M; Fornaciari M; Crocetta FM; Ghidini A
Eur J Endocrinol; 2022 Mar; 186(5):535-542. PubMed ID: 35230264
[TBL] [Abstract][Full Text] [Related]
29. Prognostic impact of serum thyroglobulin doubling-time under thyrotropin suppression in patients with papillary thyroid carcinoma who underwent total thyroidectomy.
Miyauchi A; Kudo T; Miya A; Kobayashi K; Ito Y; Takamura Y; Higashiyama T; Fukushima M; Kihara M; Inoue H; Tomoda C; Yabuta T; Masuoka H
Thyroid; 2011 Jul; 21(7):707-16. PubMed ID: 21649472
[TBL] [Abstract][Full Text] [Related]
30. Thyroidectomy for Papillary Thyroid Carcinoma.
Lo CY
Methods Mol Biol; 2022; 2534():39-56. PubMed ID: 35670967
[TBL] [Abstract][Full Text] [Related]
31. Coexistence of papillary thyroid carcinoma in secondary hyperparathyroidism.
Ma J; Mao Z; Yao Y; Lu Y; Wang H; Yang Y; Yang J; Wang W; Teng L
BMC Surg; 2021 Sep; 21(1):335. PubMed ID: 34488715
[TBL] [Abstract][Full Text] [Related]
32. Neutrophil-to-lymphocyte ratio and mural nodule height as predictive factors for malignant intraductal papillary mucinous neoplasms.
Watanabe Y; Niina Y; Nishihara K; Okayama T; Tamiya S; Nakano T
Acta Chir Belg; 2018 Aug; 118(4):239-245. PubMed ID: 29334845
[TBL] [Abstract][Full Text] [Related]
33. BRAF V600E status adds incremental value to current risk classification systems in predicting papillary thyroid carcinoma recurrence.
Prescott JD; Sadow PM; Hodin RA; Le LP; Gaz RD; Randolph GW; Stephen AE; Parangi S; Daniels GH; Lubitz CC
Surgery; 2012 Dec; 152(6):984-90. PubMed ID: 23158172
[TBL] [Abstract][Full Text] [Related]
34. Incidental Papillary Microcarcinoma and Papillary Thyroid Carcinoma in Multinodular Goiter.
Arican CD; Ozturk T; Sager MS; Sertbudak I; Teksoz S; Saricoban CT; Uygur A
Anal Cell Pathol (Amst); 2023; 2023():2768344. PubMed ID: 36691406
[TBL] [Abstract][Full Text] [Related]
35. [Therapy concept in differentiated thyroid gland carcinoma--results of 25 years with 257 patients].
Gemsenjäger E; Heitz PU; Martina B; Schweizer I
Praxis (Bern 1994); 2000 Nov; 89(44):1779-97. PubMed ID: 11109916
[TBL] [Abstract][Full Text] [Related]
36. Blood neutrophil-to-lymphocyte ratio correlates with tumor size in patients with differentiated thyroid cancer.
Liu CL; Lee JJ; Liu TP; Chang YC; Hsu YC; Cheng SP
J Surg Oncol; 2013 Apr; 107(5):493-7. PubMed ID: 22996403
[TBL] [Abstract][Full Text] [Related]
37. Excellent prognosis of patients with solitary T1N0M0 papillary thyroid carcinoma who underwent thyroidectomy and elective lymph node dissection without radioiodine therapy.
Ito Y; Masuoka H; Fukushima M; Inoue H; Kihara M; Tomoda C; Higashiyama T; Takamura Y; Kobayashi K; Miya A; Miyauchi A
World J Surg; 2010 Jun; 34(6):1285-90. PubMed ID: 20041244
[TBL] [Abstract][Full Text] [Related]
38. Comparison of Mean Platelet Volume, Platelet Count, Neutrophil/ Lymphocyte Ratio and Platelet/Lymphocyte Ratio in the Euthyroid, Overt Hypothyroid and Subclinical Hyperthyroid Phases of Papillary Thyroid Carcinoma.
Kutluturk F; Gul SS; Sahin S; Tasliyurt T
Endocr Metab Immune Disord Drug Targets; 2019; 19(6):859-865. PubMed ID: 30727930
[TBL] [Abstract][Full Text] [Related]
39. Lateral neck dissection for the treatment of synchronous and metachronous lateral neck metastasis of N1b papillary thyroid cancer.
Yun HJ; Lee JS; Lee JS; Kim SM; Chang H; Lee YS; Chang HS; Park CS
Front Endocrinol (Lausanne); 2023; 14():1166640. PubMed ID: 37424860
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of the role of prophylactic bilateral central neck lymph node dissection in patients with papillary thyroid carcinoma: a case controlled study.
Shahriarirad R; Meshkati Yazd SM; Zahedi R; Mokhtari Ardekani A; Rekabi MM; Nasiri S
Updates Surg; 2023 Apr; 75(3):679-689. PubMed ID: 36527603
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]